SNORD13D

Across TCGA pan-cancer cohorts, SNORD13D RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated SNORD13D data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher SNORD13D RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNORD13D expression acts as an unfavorable survival marker, although some lineages such as LUAD and KIRP show a favorable association.

SKCM, CHOL, and UCS are the cancer types where SNORD13D RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	IV	0.179	0.727	<.001	42	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	36	view →
UCS	OS	Tertile	All	0.321	0.626	.010	36	view →
LUAD	OS	Tertile	All	0.877	0.793	.010	33	view →
KIRP	OS	Tertile	II,III,IV	0.851	0.443	.014	30	view →
LAML	DFS	Quartile	All	0.561	0.268	.002	28	view →
LGG	OS	Median	All	0.935	0.852	.001	19	view →
BRCA	OS	Quartile	III,IV	0.959	0.885	.014	13	view →
ESCA	DFS	Quartile	All	0.535	0.323	.012	12	view →
BLCA	OS	Tertile	IV	0.712	0.230	.016	9	view →
KICH	DFS	Tertile	IV	0.269	0.784	.045	9	view →
STAD	DFS	Median	IV	0.208	0.652	.022	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

SNORD13D–SKCM (OS)

Open the SKCM breakdown →